A study of effectiveness and safety of topical combination therapy for acne vulgaris patients in dermatology department of a tertiary care teaching hospital
Keywords:Acne vulgaris, Dermatology life quality index, Effectiveness, Safety
Background: Acne vulgaris is a dermatological disorder characterised by formation of comedones and inflammatory lesions. Acne is one of the most common reason for visiting a dermatologist in early adulthood. The current line of management for mild to moderate acne is topical medications with antimicrobials and retinoids. The present study assessed the effectiveness and safety of topical combination therapy for mild to moderate acne vulgaris.
Methods: An observational, prospective and comparative study conducted on newly diagnosed acne vulgaris patients who were treated with topical combination therapy. Changes in the total, inflammatory and non-inflammatory lesion counts, investigator global assessment (IGA) and dermatology life quality index (DLQI) scales were recorded to check effectiveness. Treatment emergent adverse events were recorded in suspected ADR reporting form for safety assessment.
Results: Participants (n=97) were treated with three topical combination treatments either clindamycin-benzoyl peroxide (group-A), clindamycin-adapalene (group-B) or benzoyl peroxide-adapalene (group C). Majority of participants (42.3%) were treated with clindamycin-benzoyl peroxide group. Reduction from baseline of total, inflammatory and non-inflammatory lesion counts were highly significant within group comparison (p<0.001), but between group differences were not significant. Significant improvement in DLQI and IGA scores were noted in all three groups, but between group comparison showed no significant differences. All three groups were safe and well tolerated and equally improve participant’s quality of life.
Conclusions: all three topical combination drugs for mild acne vulgaris had similar effectiveness in terms of reduction in acne lesions with similar safety profile.
Tutakne MA, Vaishampayan SS. IAVDL Textbook of Dermatology. 3rd ed. Mumbai: Bhalani Publication House; 2008: 839-843.
Zaenglein AL, Graber EM, Thiboutot DM. Acne vulgaris and Acneiform eruptions. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editor. Fitzpatrick’s Dermatology in General Medicine. 7th ed. New York: McGraw Hill Companies; 2007: 687-703.
Gollnick HP, Zouboulis CC. Not all acne is acne vulgaris. Dtsch Arztebl Int. 2014;111(17):301-12.
Gregoriou S, Kritsotaki E, Katoulis A, Rigopoulos D. Use of tazarotene foam for the treatment of acne vulgaris. Clin Cosmet Investig Dermatol. 2014;7:165-70.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - A simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-6.
Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-73.
GraphPad Prism : Analyze, graph and present your scintific work. Available at: https://ww and w.graphpad.com/.
Seattle WI. GBD Compare. Seattle: University of Washington; 2013. Available at: http://www.healthdata.org/data-visualization/gbd-compare. Accessed on January 2019.
Gollnick HP, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1):1-37.
Gollnick HP, Draelos Z, Glenn MJ, Rosoph LA, Kaszuba A, Cornelison R, et al. Adapalene–benzoyl peroxide, a unique fixed‐dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double‐blind, controlled study in 1670 patients. Brit J Dermatol. 2009;161(5):1180-9.
Langner A, Chu A, Goulden V, Ambroziak M. A randomized, single‐blind comparison of topical clindamycin+ benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris. Brit J Dermatol. 2008;158(1):122-9.
Ghoshal L, Banerjee S, Ghosh S, Gangopadhyay D, Jana S. Comparative evaluation of effectiveness of adapalene and azithromycin, alone or in combination, in acne vulgaris. Ind J Dermatol. 2007;52(4):179.
Dubey A, Amane H. Comparison of efficacy and safety of adapalene and benzoyl peroxide- clindamycin combination in the topical treatment of acne vulgaris. IJBCP. 2016;5(5):1727-32.
Al‐Ameer AM, Al‐Akloby OM. Demographic features and seasonal variations in patients with acne vulgaris in Saudi Arabia: a hospital‐based study. Inter J Dermatol. 2002;41(12):870-1.
Poli F, Auffret N, Beylot C, Chivot M, Faure M, Moyse D, et al. Acne as seen by adolescents: results of questionnaire study in 852 French individuals. Acta Dermato-Venereol. 2011;91(5):531-6.
Balakrishnan J, Appalasamy JR, Verma RA. study on awareness of skin infection among adults in petaling district, Malaysia. Int J Pharm Pharm Sci. 2015;8(2):136-9.
Darwish MA, Al-rubaya AA. Knowledge , Beliefs , and Psychosocial Effect of Acne Vulgaris among Saudi Acne Patients. ISRN Dermatol. 2013: 1-6.
Adityan B, Thappa DM. Pro Þ le of acne vulgaris- A hospital-based study from South India. Ind J Dermatol, Venereol Leprol. 2009;75(3):272.
Gollnick HPM, Friedrich M, Peschen M, Pettker R, Pier A, Streit V, et al. Safety and efficacy of adapalene 0.1% / benzoyl peroxide 2.5% in the long-term treatment of predominantly moderate acne with or without concomitant medication - results from the non-interventional cohort study ELANG. J Europ Acad Dermatol Venereol. 2015;29(4):15-22.
Dudhia S, Shah RB, Agrawal P, Shah A, Date S. Efficacy and safety of clindamycin gel plus either benzoyl peroxide gel or adapalene gel in the treatment of acne: a randomized open-label study. Drugs Ther Perspect. 2015: 3-7.
Choudhury S, Chatterjee S, Sarkar DK, Dutta RN. Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: A randomized controlled trial. Ind J Pharmacol. 2011;43(6):628-31.
Kaur J, Sehgal VK, Gupta AK, Singh SP. A comparative study to evaluate the efficacy and safety of combination topical preparations in acne vulgaris. Int J Appl Basic Med Res. 2015;5(2):106-10.
Shwetha H, Geetha A, Revathi TN. Research Article A comparative study of efficacy and safety of combination of topical 1 % peroxide in mild to moderate acne at a tertiary care hospital. J Chem Pharmaceut Res. 2014;6(2):736-41.
Wolf Jr JE, Kaplan D, Kraus SJ, Loven KH, Rist T, Swinyer LJ, et al. Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: A multicenter, randomized, investigator-blinded study. J Am Acad Dermatol. 2003;49(3):211-7.
Reddy NB, Nandimath MK. Comparison of clinical efficacy of topical clindamycin with adapalene and adapalene alone in treatment of mild to moderate facial acne vulgaris. Int J Pharm Bio Sci. 2013;4:1079-88.
Prasad S, Mukhopadhyay A, Kubavat A, Kelkar A, Modi A, Swarnkar B, et al. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0. 1 % and clindamycin 1 % combination in acne vulgaris: A randomized , open label , active-controlled , multicentric, phase IV clinical trial. Indian J Dermatol Venereol Leprol. 2012;78(4):459-67.
Thiboutot DM, Weiss J, Bucko A, Eichenfield L, Jones T, Clark S, et al. Combination for the treatment of acne vulgaris : Results of a multicenter , randomized double-blind , controlled study. J Am Acad Dermatol. 2007;57(5):791-9.